viewray.com
ViewRay Des traitements radiologiques visiblement différents
http://www.viewray.com/fr_index
Ciblage de Tissus Mous. Ce que vous ne pouvez visualiser? À partir de l’imagerie. Une tumeur qui se déplace constamment? Nous transformons une hypothèse. En réalité grâce à la visualisation. Comment pouvez-vous tenir compte. Des évolutions dans la tumeur? Nous délivrons plus que du traitement réactif,. Nous réalisons une radiothérapie adaptative. Le premier et seul. Et traitant des patients. MRIdian vous permet de voir la cible à traiter en temps réel tout au long du traitement. C’est une révolution!
viewray.com
ViewRay - Motion Management To adapt to motion, first you have to see it
http://www.viewray.com/motion
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. To adapt to motion, first you have to see it. MRI is the clinically preferred method of imaging soft tissue. MRI technology can give clinicians a clearer view of the patient’s internal organs, such as the lung, without delivering the extra ionizing radiation of CT imaging (below). While the treatment beam is on. Mdash;along with the tools to refine the target and reoptimize the dose while the patient is on the treatment table.
viewray.com
ViewRay - Patient Positioning - High-quality soft-tissue imaging for accurate pretreatment positioning
http://www.viewray.com/position_patient
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. High-quality soft-tissue imaging for accurate patient positioning. With the MRIdian system, MR imaging can be used for planning and daily positioning as well as for precision targeting during treatment. Positioning accuracy requires high-quality images, and MRIdian's MRI subsystem delivers excellent soft-tissue contrast. Pretreatment imaging fits into a conventional timeslot, similar to the timeslot required for cone-beam CTs...
viewray.com
ViewRay - Company - A new kind of medical technology company
http://www.viewray.com/company
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. A new kind of medical technology company. Radiation therapy and imaging technologies. Siteman Cancer Center at Barnes‐Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri. University of California, Los Angeles (UCLA) Health System Jonsson Comprehensive Cancer Center. University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. 2 Thermo Fisher Way. Oakwood Village, Ohio 44146. ViewRay Annou...
viewray.com
ViewRay - Patient information center
http://www.viewray.com/patient_information
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. Find a MRIdian Treatment Center. Radiation therapy information from the American Cancer Society. A guide to radiation therapy for patients and families from the American Cancer Society, a U.S.-based nonprofit organization. People Living with Cancer. Information about cancer types, treatments, research, and other news from clinicians at the American Society of Clinical Oncology (ASCO). Association of Cancer Online Resources (ACOR).
viewray.com
ViewRay - Nonstop imaging supports advanced therapy techniques
http://www.viewray.com/treatment
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. Nonstop imaging supports advanced therapy techniques. On-table dose prediction and adaptive optimization. Treatment delivery, with continuous MR imaging and soft-tissue targeting. Clinical review and assessment. MRI guidance and intelligent software deliver advantages throughout the treatment process:. Mdash;High-quality, volumetric soft-tissue imaging for accurate pretreatment positioning. By capturing imaging and motion data t...
viewray.com
ViewRay - News
http://www.viewray.com/latest_news
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. Learn about the latest developments at ViewRay. Find background information, frequently asked questions, and downloadable images in the ViewRay press kit. Henry Ford to Acquire ViewRay MRIdian Linac Research System. September 1, 2016. ViewRay Announces $13.75 Million Private Placement. August 19, 2016. ViewRay Reports Second Quarter 2016 Financial Results. August 15, 2016. August 15, 2016. August 8, 2016. August 4, 2016.
viewray.com
ViewRay - Review and Assessment - Software tools help physicians better understand and manage treatment progress
http://www.viewray.com/assess
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. Software tools help physicians better understand and manage treatment progress. Clinical review and assessment. With detailed data and powerful review and assessment tools, physicians can fine-tune prescriptions based on. Evidence of organ motion and the actual dose delivered —with each treatment. With the MRIdian system, physicians have the tools to:. Track target and organ positions. Predict and Optimize Dose. August 24, 2016.
viewray.com
ViewRay - Dose Prediction and Optimization -Accurate dose prediction for on-table quality assurance and plan adaptation
http://www.viewray.com/optimize_dose
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. Accurate dose prediction for on-table quality assurance and plan adaptation. On-table dose prediction and reoptimization. Using advanced deformation and autocontouring algorithms, the MRIdian system can quickly capture a volumetric soft-tissue image, deformally register it to the planning image, incorporate the dose rate, gantry position, and leaf sequence, and predict the dose to be delivered. Predict and Optimize Dose. ViewRay...
viewray.com
ViewRay - Advisory Boards - ViewRay leaders combine expertise in business and medical technology
http://www.viewray.com/advisory_boards
Predict and Optimize Dose. ViewRay in the News. Please type and press enter. ViewRay draws on experience of industry leaders. In this four-minute video. Members of ViewRay's Scientific and Clinical Advisory Boards talk about the need for—and the potential of—the MRIdian system. "We believe this could be a paradigm changer in our field," says Sasa Mutic, PhD, professor of radiation oncology at Washington University. Chris A. Raanes. James Dempsey, PhD. Josh Bilenker, MD. David Bonita, MD. Mark Gold, MD.
